Navigation Links
At small scales, tug-of-war between electrons can lead to magnetism
Date:6/30/2011

BUFFALO, N.Y. -- At the smallest scales, magnetism may not work quite the way scientists expected, according to a recent paper in Physical Review Letters by Rafał Oszwałdowski and Igor utić of the University at Buffalo and Andre Petukhov of the South Dakota School of Mines and Technology.

The three physicists have proposed that it would be possible to create a quantum dot -- a kind of nanoparticle -- that is magnetic under surprising circumstances.

Magnetism is determined by a property all electrons possess: spin. Individual spins are akin to tiny bar magnets, which have north and south poles. Electrons can have an "up" or "down" spin, and a material is magnetic when most of its electrons have the same spin.

Mobile electrons can act as "magnetic messengers," using their own spin to align the spins of nearby atoms. If two mobile electrons with opposite spins are in an area, conventional wisdom says that their influences should cancel out, leaving a material without magnetic properties.

But the UB-South Dakota team has proposed that at very small scales, magnetism may be more nuanced than that. It is possible, the physicists say, to observe a peculiar form of magnetism in quantum dots whose mobile electrons have opposing spins.

In their Physical Review Letters article (http://www.buffalo.edu/news/pdf/June11/Paper1.pdf), the researchers describe a theoretical scenario involving a quantum dot that contains two free-floating, mobile electrons with opposite spins, along with manganese atoms fixed at precise locations within the quantum dot.

The quantum dot's mobile electrons act as "magnetic messengers," using their own spins to align the spins of nearby manganese atoms.

Under these circumstances, conventional thinking would predict a stalemate: Each mobile electron exerts an equal influence over spins of manganese atoms, so neither is abl
'/>"/>

Contact: Charlotte Hsu
chsu22@buffalo.edu
716-645-4655
University at Buffalo
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract
2. Reportlinker Adds Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
3. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
4. Pitt-led researchers create super-small transistor, artificial atom powered by single electrons
5. Precision Therapeutics ChemoFx® Demonstrates Significant Role in Selection of Chemotherapy Doublets in Non Small Cell Lung Cancer
6. The worlds smallest wedding rings
7. MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
8. Top-Line Results Announced of Pivotal Phase 3 Motesanib Trial in Advanced Non-Squamous Non-Small Cell Lung Cancer Patients
9. 3-D printing method advances electrically small antenna design
10. Quantum hot potato: NIST researchers entice 2 atoms to swap smallest energy units
11. Smallest magnetic field sensor in the world
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
At small scales, tug-of-war between electrons can lead to magnetism
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)... LOUIS, July 30, 2015 HIGHLIGHTS:Q2 ... in 2014) , Reported sales were $697 million ... 2014.  Sales grew organically by 8%, and changes in ... acquisitions increased sales by 1%. , By business ... in Applied and 11% in SAFC Commercial. , ...
(Date:7/29/2015)... , July 30, 2015 ... la santé, publie ses résultats pour le premier ... commente les résultats. Visionner l,interview ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de ... - Moteurs de croissance - ...
(Date:7/29/2015)...  HealthSouth Corporation (NYSE: HLS ), ... healthcare services, offering both facility-based and home-based post-acute ... the second quarter ended June 30, 2015. ... volume growth in both segments and an 11.0% ... President and Chief Executive Officer of HealthSouth. "While ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15
... Tumor Protection In Vivo; Lead Candidate May Have Utility ... ... SAN DIEGO, CA, Sept. 24 /PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals Corporation ... lead therapeutic vaccine candidate for the treatment,of human papillomavirus (HPV)-related ...
... Detection of HPV Viral Load a Possible Indicator of Cervical ... ... Sept. 24 Cepheid (Nasdaq:,CPHD) today announced that it has entered ... held by Quantovir,AB of Sweden for the quantitative measurement of high-risk ...
... September 24 ProImmune Ltd., a leading,provider of quality ... antigen discovery, has announced the launch of its new,MHC-peptide ... the series of,discovery services for Class I HLA already ... binding assay for HLA alleles DR1-4, is a,powerful cell-free ...
Cached Biology Technology:Nventa announces publication of HspE7 data 2Nventa announces publication of HspE7 data 3Nventa announces publication of HspE7 data 4Nventa announces publication of HspE7 data 5Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 2Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 3Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 4ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles 2
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... the Advancement of Science (AAAS) has named Dr. J. ... University of Colorado School of Medicine, as winner of ... Award., Cohen was honored for his outstanding achievements in ... series of free lectures on science and medicine, informal ...
... ANN ARBOR, Mich.---Rising carbon dioxide levels associated with global ... that eat them, altering the course of plant evolution, ... The research focused on the effects of elevated carbon ... of many plants that produce toxic or bitter chemical ...
... short stature is not usually cause for concern, but it ... syndrome. Prevalent in girls, Turner syndrome is a genetic defect ... problems. It is not commonly detected until age 10 or ... This lag before diagnosis of the condition can delay ...
Cached Biology News:Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 2Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 3Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 4Global warming may reroute evolution 2New test shows promise for accurate diagnosis of Turner syndrome 2
FEN-1 (B-4)...
Secure-Seal™ spacer, one well, 20 mm diameter, 0.12 mm deep *set of 100*...
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells....
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
Biology Products: